CDGP Case Discussion: Short Stature & Delayed Pubert... | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Case Discussion ](https://mdster.com/blog?category=case-discussion) 4. Constitutional Delay of Growth and Puberty (CDGP): A Case Discussion on Short Stature and Delayed Puberty [ Case Discussion ](https://mdster.com/blog?category=case-discussion) Constitutional Delay of Growth and Puberty (CDGP): A Case Discussion on Short Stature and Delayed Puberty =========================================================================================================== How to distinguish a normal variant from hypogonadism, chronic disease, or intracranial pathology—using growth tempo, bone age, and targeted labs. [ MDster Editorial Team ](https://mdster.com/about) · Feb 28, 2026 · 6 min read · 100 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Board Review ](https://mdster.com/blog?tag=board-review) [ Pediatrics ](https://mdster.com/blog?tag=pediatrics) [ Pediatric Endocrinology ](https://mdster.com/blog?tag=pediatric-endocrinology) [ Delayed Puberty ](https://mdster.com/blog?tag=delayed-puberty) [ Short Stature ](https://mdster.com/blog?tag=short-stature) [ Case Discussion ](https://mdster.com/blog?tag=case-discussion) Share this article Share this post A 13-year-old who is still Tanner 1 is rarely “just short” to the patient in front of you—he’s the kid avoiding locker rooms, getting teased, and watching peers surge ahead. Your job is to be simultaneously conservative (not medicalizing a normal variant) and intolerant of missed pathology (primary gonadal failure, CNS disease, or chronic inflammatory states that quietly flatten puberty and growth). Case vignette ------------- A 13-year-old boy is referred for short stature and absent pubertal development. Height 136 cm and weight 31 kg are both <3rd percentile. Growth velocity has been ~4.5 cm/year, tracking parallel to the lower percentiles. He is well-appearing, normotensive, and without headaches, visual changes, chronic diarrhea, cough, or systemic symptoms. Pubertal exam shows Tanner 1 pubic hair and symmetric testicular volume 2 mL bilaterally. He has no goiter, no midline defects, and reports a normal sense of smell. Dad describes himself as a “late bloomer,” with growth into early college. CBC and CMP are normal. A left hand/wrist bone age returns **delayed by ~2 years** (e.g., bone age ~11 years), without dysmorphic skeletal features. Real-time clinical reasoning: why CDGP rises to the top ------------------------------------------------------- Three elements should anchor your pre-test probability. First, the **tempo**: his growth velocity is maintained and parallel—this argues against classic endocrine growth failure where velocity typically decelerates. Second, the **family pattern**: a “late bloomer” parent is not diagnostic, but it meaningfully shifts the odds. Third, the **concordant delay**: short stature plus delayed puberty plus a delayed bone age that “matches” the child’s physiologic immaturity is the CDGP signature. What keeps you honest is the definition line in boys: **absence of testicular enlargement (≥4 mL) by age 14** is delayed puberty. At 13, you’re often managing *risk* and *trajectory* more than you’re labeling a condition. Consequently, the best clinicians resist the reflex to order everything up front, while still covering the small set of diagnoses you cannot miss. Differential diagnosis: pattern recognition with a short list of high-yield discriminators ------------------------------------------------------------------------------------------ In practice, the differential is less about memorizing causes and more about identifying which “lane” the patient belongs to: normal-variant delay (CDGP), functional suppression, permanent hypogonadotropic hypogonadism, or primary gonadal failure. PatternClues that push you thereNext best tests/actions**CDGP**Normal growth velocity; delayed bone age; family history; otherwise healthyTargeted screening labs; follow growth/puberty over 6–12 months**Functional hypogonadotropic hypogonadism** (chronic disease/undernutrition)Low/declining weight percentile, systemic symptoms, inflammation, disordered eating, high training loadESR/CRP, celiac serologies, thyroid studies; treat underlying condition**Permanent hypogonadotropic hypogonadism** (e.g., Kallmann)No spontaneous progression over time; micropenis/cryptorchid history (sometimes); **anosmia** in Kallmann; possible midline defectsEarly-morning LH/FSH/testosterone ± MRI depending on context; consider genetics**Hypergonadotropic hypogonadism** (primary gonadal failure)Small/firm testes; learning differences/gynecomastia (Klinefelter); elevated gonadotropinsLH/FSH (high), karyotype when indicated A key nuance: early labs can be unhelpful because prepubertal gonadotropins overlap across conditions. So the “best” discriminator is often **time** (lack of progression) plus **bone age context**, not a single hormone value. > **Clinical Pearl:** In a boy with short stature and absent puberty, a **delayed bone age with preserved growth velocity** is more reassuring than a “normal” screening lab panel—because tempo is harder to fake than a single number. Targeted workup: enough to rule out the dangerous and the common ---------------------------------------------------------------- Even when CDGP is likely, you still owe the patient a focused exclusion of common, treatable pathology—especially conditions that present without dramatic symptoms. I typically start with four categories: - **Thyroid axis:** TSH and free T4. Hypothyroidism can quietly suppress growth and puberty. - **Growth hormone sufficiency screen:** IGF-1 (interpreted against bone age/puberty stage, not just chronologic age). A low IGF-1 is not a diagnosis; it’s a prompt to re-check context and consider formal testing if the phenotype fits. - **Inflammation/chronic disease:** ESR and/or CRP, plus history that you re-ask with intent (stool frequency, nocturnal symptoms, fatigue, fevers, joint pain). - **Celiac screening:** tissue transglutaminase IgA with total IgA (short stature can be the only clue). Where do LH/FSH/testosterone fit? They’re often obtained, but their interpretation depends on whether you’re asking “Is he entering puberty?” or “Is this permanent hypogonadism?” In a 13-year-old Tanner 1 boy, a low early-morning testosterone is expected. What becomes more informative is the **trajectory**: if he reaches 14–15 without testicular enlargement, repeating gonadotropins and testosterone (and considering stimulation testing in specialist settings) becomes more diagnostically consequential. Neuroimaging is not routine in an otherwise well child with normal neurologic exam and no headaches/visual changes. Clinical judgment dictates a lower threshold if there are red flags (rapid deceleration of growth velocity, polyuria/polydipsia, hyperprolactinemia, or other pituitary deficits). Management: reassurance is active care, not “do nothing” -------------------------------------------------------- For a 13-year-old who is likely CDGP, the highest-value interventions are (1) **prediction and planning**, and (2) **psychosocial triage**. Families worry about adult height; patients worry about being last. Counseling should explicitly connect the delayed bone age to prognosis: delayed skeletal maturation means **more remaining growth potential** and typically an adult height near mid-parental expectation, just achieved later. I am careful not to overpromise precision—adult height prediction from bone age is probabilistic, and adolescent growth is messy. Follow-up is where CDGP is “confirmed.” A reasonable plan is re-evaluation in 6 months with interval growth velocity and pubertal exam (testicular volume is the most useful single metric). If testicular volume begins to rise, you can often avoid further testing. When distress is significant—classically in an older boy (often ~14.5 years or older) with persistent prepubertal exam—many clinicians consider a **brief, low-dose testosterone course** to initiate virilization and alleviate psychosocial burden. The intent is not to “finish puberty,” but to nudge the system and buy time while endogenous HPG activation declares itself. Regimens vary by practice; a common approach is monthly IM testosterone at low doses for a limited duration with reassessment for spontaneous testicular enlargement afterward. The exam-relevant point is the strategy: **short course, low dose, reassess**, rather than chronic replacement. When the story changes: failure to progress after testosterone -------------------------------------------------------------- Now imagine he returns at 15. He completed a prior testosterone course, but testicular volume remains 2 mL with no spontaneous enlargement. At this point, CDGP becomes less comfortable, because CDGP is fundamentally a delay—not an absence—of central activation. Your next questions become sharper: Was the sense of smell truly normal? Any history of cryptorchidism or micropenis? Any subtle midline anomalies? Kallmann syndrome classically pairs hypogonadotropic hypogonadism with **anosmia/hyposmia** due to disrupted GnRH neuron migration. Conversely, if LH/FSH are **elevated**, you pivot away from central causes toward **primary gonadal failure**, where hypergonadotropic labs help separate it from CDGP. This is also where you stop treating “distress” alone and start treating a potential lifelong endocrine diagnosis. Management shifts toward a complete hypogonadism evaluation, counseling about fertility implications, and a longer-term pubertal induction plan tailored to etiology and family goals. Clinical application: what to document and what to revisit ---------------------------------------------------------- The highest-yield documentation is serial: height/weight percentiles, **growth velocity**, and **testicular volume** over time, with bone age interpreted in context. In parallel, name the uncertainty out loud: “Most consistent with CDGP today; we will prove it by progression.” That framing reduces family anxiety and prevents the common error of repeated scattered testing without a plan. Finally, treat teasing and isolation as clinical problems. If you’re considering testosterone solely because the family is anxious, pause; if you’re considering it because the patient is avoiding school and spiraling socially, you’re in a different ethical space where symptom relief matters. Key Points for Board Exams -------------------------- - Delayed puberty in boys: **no testicular enlargement (≥4 mL) by age 14**. - **CDGP**: preserved growth velocity, **delayed bone age**, family history often present; adult height usually near genetic potential but achieved later. - Screening labs to rule out common pathology: **TSH/free T4**, **IGF-1**, **ESR/CRP**, **tTG-IgA with total IgA**. - **Hypergonadotropic hypogonadism**: elevated LH/FSH suggests primary gonadal failure and differentiates it from CDGP. - **Kallmann syndrome** clue: **anosmia/hyposmia**; think permanent hypogonadotropic hypogonadism when there’s no progression by mid-adolescence. Key Points Summary ------------------ - The “most reassuring triad” is **parallel growth**, **delayed bone age**, and **family history**—but the diagnosis is ultimately confirmed by **time and progression**. - Use labs to exclude treatable disease, not to replace longitudinal assessment. - Consider a limited testosterone course when older adolescents have persistent prepubertal findings plus meaningful psychosocial distress, with planned reassessment. - Lack of spontaneous testicular enlargement by ~15 (especially after a testosterone trial) should trigger re-evaluation for **permanent hypogonadism**. Conclusion ---------- This case looks like CDGP because the tempo is steady, the bone age is delayed, and the family story fits—but the real clinical skill is committing to a *followable hypothesis*. If puberty declares itself, you’ve spared the patient unnecessary labeling and testing. If it doesn’t, you pivot early enough to diagnose hypogonadism while still delivering what the patient needed all along: a plan that matches both physiology and lived experience. Keep going Practice Pediatrics the way boards test ----------------------------------------- - Age‑specific differentials and management - Growth, development, and immunizations - Target weak areas with smart review [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Pediatrics ](https://mdster.com/speciality/pediatrics) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() Related Posts ------------- [ ![Neonatal Septic Shock in the ED: A High-Yield Case Discussion](https://mdster.com/storage/blog/images/neonatal-septic-shock-in-the-ed-a-high-yield-case-discussion.jpg) Case Discussion ### Neonatal Septic Shock in the ED: A High-Yield Case Discussion An ill 18-day-old with fever, lethargy, shock, and hypoglycemia demands parallel resuscitation and sepsis management. This case reviews ED priorities, LP timing, antibiotics, HSV coverage, and board pearls. 6 min read 0 comments ](https://mdster.com/blog/neonatal-septic-shock-in-the-ed-a-high-yield-case-discussion) [ ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg) Medical Education ### IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy A focused Internal Medicine review of IBS diagnosis: how to use Rome IV concepts, separate IBS-C from IBS-D and mixed IBS, and decide when colonoscopy is truly indicated. 7 min read 0 comments ](https://mdster.com/blog/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy) [ ![Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes](https://mdster.com/storage/blog/images/congenital-hypothyroidism-screening-levothyroxine-outcomes.jpg) Medical Education ### Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes High-yield review of congenital hypothyroidism for Pediatrics trainees, covering newborn screening pitfalls, urgent levothyroxine treatment, and developmental follow-up. 6 min read 0 comments ](https://mdster.com/blog/congenital-hypothyroidism-screening-levothyroxine-outcomes) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept